About 34 results found for searched term "Phospholipase" (0.093 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M49416 | Recombinant Human PLA2G2A Protein (HEK293, C-His) | Recombinant Proteins |
| Phospholipase A2 group IIA | ||
| PLA2G2A, is a peripheral membrane protein that belongs to the phospholipase A2 family. PLA2G2A plays a role in anti-bacterial defense, inflammation and eicosanoid generation, in clearance of apoptotic cells, and in the Wnt signaling pathway. | ||
| M49417 | Recombinant Mouse PLA2G2A Protein (Yeast, C-His) | Recombinant Proteins |
| Phospholipase A2 group IIA | ||
| PLA2G2A, is a peripheral membrane protein that belongs to the phospholipase A2 family. PLA2G2A plays a role in anti-bacterial defense, inflammation and eicosanoid generation, in clearance of apoptotic cells, and in the Wnt signaling pathway. | ||
| M50304 | Phospholipase C | Enzymes & Coenzymes |
| Phospholipase C (PLCs) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. | ||
| M52550 | Phospholipase A2 | Phospholipase |
| Phospholipase A2 (PLA2) catalyzes the hydrolysis of the sn-2 position of membrane glycerophospholipids to liberate arachidonic acid (AA). | ||
| M2176 | Dexamethasone | Animal Modeling |
| Prednisolone F; Hexadecadrol | ||
| Dexamethasone (Hexadecadrol) is a glucocorticoid receptor agonist that induces the production of phospholipase A2 inhibitory protein.It can be used to construct models of allergic conjunctivitis. | ||
| M2528 | Clofazimine | Anti-infection |
| Clofazimine is a rhimophenazine dye, originally developed for the treatment of tuberculosis, it has both antimicrobial and antiinflammatory activity, postulated mechanisms of action include intercalation of clofazimine with bacterial DNA and increasing levels of cellular phospholipase A2. | ||
| M2626 | Dexamethasone Sodium Phosphate | Animal Modeling |
| Dexamethasone phosphate disodium | ||
| Dexamethasone Sodium Phosphate is a glucocorticoid receptor agonist that induces the production of lipocortin, a phospholipase A2 inhibitory protein. Dexamethasone inhibits autophagy levels in damaged cells in a dose-dependent manner. It can be used to construct models of allergic conjunctivitis. | ||
| M5170 | U73122 | Phospholipase |
| U-73122 | ||
| U73122 is a potent inhibitor of phospholipase C, phospholipase A2 and 5-LO (5-lipoxygenase). | ||
| M5855 | Rilapladib | Phospholipase |
| SB 659032 | ||
| Rilapladib (SB 659032) is a selective Lp-PLA2 (lipoprotein-associated phospholipase A2) inhibitor with an IC50 of 230 pM. Rilapladib (SB 659032) is also a PAFR (Platelet Activating Factor Receptor) antagonist. | ||
| M6979 | ML 348 | Others |
| ML 348 is a selective and reversible lysophospholipase 1 (LYPLA1) inhibitor. | ||
| M6980 | ML 349 | Others |
| ML 349 is a selective and reversible lysophospholipase 2 (LYPLA2) inhibitor. | ||
| M7076 | OBAA | Others |
| OBAA is a phospholipase A 2 inhibitor. | ||
| M7591 | Arachidonyl trifluoromethyl ketone | Phospholipase |
| Inhibits anandamide hydrolysis in vitro; inhibits phospholipase A2. | ||
| M7830 | Halopemide | Others |
| Halopemide is a dopamine receptor antagonist and a phospholipase D2 inhibitor. | ||
| M7894 | LY311727 | Others |
| LY311727 is an oral active compound; Phospholipase A2 (sPLA2; Group activity highlights) inhibitors. | ||
| M7922 | MJ33 lithium salt | Others |
| Novel, active site directed, specific, competitive and reversible inhibitor of phospholipase A2 (PLA2). | ||
| M8168 | sPLA2 inhibitor | Phospholipase |
| Secretory phospholipase A2 inhibitor blocks the activation of NF-κB, Akt, p38 MAPK and ERK pathways. | ||
| M8478 | YM-26734 | Others |
| YM-26734 is a competitive inhibitor of the secreted (Group II) form of phospholipase A2. | ||
| M8731 | ASB14780 | Others |
| ASB14780 is an indole-based selective and potent cytosolic phospholipase A2α inhibitor (IC50 = 20 nM/cPLA2α and >10 μM/sPLA2α). | ||
| M8927 | VU-0155069 | Phospholipase |
| VU-0155069 is a potent and selective phospholipase D1 (PLD1) inhibitor. | ||
| M14508 | 3-Nitrocoumarin | Phospholipase |
| 3-Nitrocoumarin (3-NC) is a potent and selective Phospholipase C-γ (PLC-γ) inhibitor. | ||
| M14509 | CAY10650 | Phospholipase |
| CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion. | ||
| M14510 | D609 | Phospholipase |
| D609 is a selective competitive inhibitor of phosphatidyl choline-specific phospholipase C (PC-PLC), with Ki of 6.4 μM. | ||
| M14511 | LEI-401 | Phospholipase |
| LEI-401 is a first-in-class, selective, and CNS-active NAPE-PLD (N-acylphosphatidylethanolamine phospholipase D) inhibitor, with an IC50 of 27 nM. | ||
| M14514 | N-(p-amylcinnamoyl) Anthranilic Acid | Phospholipase |
| ACA | ||
| N-(p-amylcinnamoyl) Anthranilic Acid (ACA) is a broad spectrum Phospholipase A2 (PLA2) inhibitor and TRP channel blocker. | ||
| M14515 | Varespladib methyl | Phospholipase |
| A-002; LY333013 | ||
| Varespladib methyl (A-002; LY333013) is a selective inhibitor of group II secretory phospholipase A2 (PLA2). | ||
| M20582 | ST 271 | Phospholipase |
| ST271 is a tyrphostin-like protein tyrosine kinase (PTK) inhibitor which inhibits phospholipase D (PLD) activity. | ||
| M21681 | Compound 48/80 trihydrochloride | Phospholipase |
| C48/80 trihydrochloride | ||
| Compound 48/80 trihydrochloride is widely used in animal and tissue models as a "selective" mast cell activator. Compound 48/80 acts at the mast cell membrane to stimulate trimeric G-proteins and induces degranulation via phospholipase C and D pathways. | ||
| M27746 | FKGK11 | Phospholipase |
| FKGK11 is a potent and selective inhibitor of GVIA iPLA2 (Group VIA calcium-independent phospholipase A2). FKGK11 can be used for the research of ovarian cancer and neurological disorders such as peripheral nerve injury and multiple sclerosis. | ||
| M28097 | BAPTA tetrasodium | Phospholipase |
| BAPTA | ||
| BAPTA tetrasodium is a selective chelator for calcium. BAPTA tetrasodium, as calcium indicator, has high selectivity against magnesium and calcium. BAPTA tetrasodium is widely used as an intracellular buffer for investigating the effects of Ca2+ release from intracellular stores or influx via Ca2+-permeable channels in the plasma membrane. BAPTA tetrasodium can also inhibit phospholipase C activity independently of their role as Ca2+ chelators. | ||
| M28382 | Lp-PLA2-IN-1 | Phospholipase |
| Lp-PLA2-IN-1 is a potent Lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor. Lp-PLA2-IN-1 has the potential for atherosclerosis, Alzheimer's disease research. | ||
| M28835 | Me-Indoxam | Phospholipase |
| Me-Indoxam is a potent and cell-impermeable secreted phospholipase A2 (sPLA2) inhibitor. | ||
| M28836 | Varespladib sodium | Phospholipase |
| LY315920 sodium | ||
| Varespladib sodium (LY315920 sodium) is a potent and selective group IIA, secretory phospholipase A2 (sPLA2) inhibitor with an IC50 of 9 nM. Varespladib sodium exhibits the significant inhibitory effect on sPLA2 activity in serum from various species including rat, rabbit, guinea pig and human with IC50s of 8.1 nM, 5.0 nM, 3.2 nM and 6.2 nM, respectively. | ||
| M29064 | LYPLAL1-IN-1 | Others |
| LYPLAL1-IN-1 (Compound 11) is an selective covalent small-molecule inhibitor of Lysophospholipase-like 1 (LYPLAL1) with an IC50 of 0.006 μM. LYPLAL1-IN-1 increases glucose production. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
